BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.Signal Transduct Target Ther. 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 124] [Article Influence: 27.5] [Reference Citation Analysis]
Number Citing Articles
1 Konstantinou GN. Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach. Hum Vaccin Immunother 2022;18:2050654. [PMID: 35412949 DOI: 10.1080/21645515.2022.2050654] [Reference Citation Analysis]
2 Hashimoto R, Takahashi J, Shirakura K, Funatsu R, Kosugi K, Deguchi S, Yamamoto M, Tsunoda Y, Morita M, Muraoka K, Tanaka M, Kanbara T, Tanaka S, Tamiya S, Tokunoh N, Kawai A, Ikawa M, Ono C, Tachibana K, Kondoh M, Obana M, Matsuura Y, Ohsumi A, Noda T, Yamamoto T, Yoshioka Y, Torisawa YS, Date H, Fujio Y, Nagao M, Takayama K, Okada Y. SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression. Sci Adv 2022;8:eabo6783. [PMID: 36129989 DOI: 10.1126/sciadv.abo6783] [Reference Citation Analysis]
3 Terrassoux L, Claux H, Bacari S, Meignan S, Furlan A. A Bloody Conspiracy. Blood Vessels and Immune Cells in the Tumor Microenvironment. Cancers 2022;14:4581. [DOI: 10.3390/cancers14194581] [Reference Citation Analysis]
4 Prasad AS, Malysa A, Bepler G, Fribley A, Bao B. The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19. Antioxidants 2022;11:1862. [DOI: 10.3390/antiox11101862] [Reference Citation Analysis]
5 Heubner L, Greiner M, Vicent O, Beyer-Westendorf J, Tiebel O, Scholz U, Güldner A, Mirus M, Fries D, Koch T, Spieth PM. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study. Thromb J 2022;20:48. [PMID: 36038895 DOI: 10.1186/s12959-022-00403-0] [Reference Citation Analysis]
6 Thongin S, Den-Udom T, Uppakara K, Sriwantana T, Sibmooh N, Laolob T, Boonthip C, Wichai U, Muta K, Ketsawatsomkron P. Beneficial effects of capsaicin and dihydrocapsaicin on endothelial inflammation, nitric oxide production and antioxidant activity. Biomed Pharmacother 2022;154:113521. [PMID: 36007275 DOI: 10.1016/j.biopha.2022.113521] [Reference Citation Analysis]
7 Kubatka P, Mazurakova A, Koklesova L, Samec M, Sokol J, Samuel SM, Kudela E, Biringer K, Bugos O, Pec M, Link B, Adamkov M, Smejkal K, Büsselberg D, Golubnitschaja O. Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00293-2] [Reference Citation Analysis]
8 Zhang R, Sun C, Han Y, Huang L, Sheng H, Wang J, Zhang Y, Lai J, Yuan J, Chen X, Jiang C, Wu F, Wang J, Fan X, Wang J. Neutrophil autophagy and NETosis in COVID-19: perspectives. Autophagy 2022;:1-10. [PMID: 35951555 DOI: 10.1080/15548627.2022.2099206] [Reference Citation Analysis]
9 Kubra KT, Akhter MS, Saini Y, Kousoulas KG, Barabutis N. Activating transcription factor 6 protects against endothelial barrier dysfunction. Cell Signal 2022;:110432. [PMID: 35933031 DOI: 10.1016/j.cellsig.2022.110432] [Reference Citation Analysis]
10 Naidoo N, Moodley J, Khaliq OP, Naicker T. Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A Review. Virus Res 2022;:198880. [PMID: 35905790 DOI: 10.1016/j.virusres.2022.198880] [Reference Citation Analysis]
11 Zhou W, Chen Z, Fang Z, Xu D. Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure. Comput Biol Med 2022;148:105845. [PMID: 35849948 DOI: 10.1016/j.compbiomed.2022.105845] [Reference Citation Analysis]
12 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Reference Citation Analysis]
13 Mutahar AZI, Devaramani M, Dayal R, Saini DK, Salimath PV, Salimath BP. Vascular Endothelial Growth Factor Receptor, fms-Like Tyrosine Kinase-1 (Flt-1), as a Novel Binding Partner for SARS-CoV-2 Spike Receptor-Binding Domain. Front Immunol 2022;13:906063. [DOI: 10.3389/fimmu.2022.906063] [Reference Citation Analysis]
14 Al-Mustanjid M, Mahmud SH, Akter F, Rahman MS, Hossen MS, Rahman MH, Moni MA. Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. Inform Med Unlocked 2022;:101003. [PMID: 35818398 DOI: 10.1016/j.imu.2022.101003] [Reference Citation Analysis]
15 Al Qawasmeh M, Ahmed YB, Nsour OA, Qarqash AA, Al-Horani SS, Hazaimeh EA, Jbarah OF, Yassin A, Aldabbour B, Alhusban A, El-Salem K. Functional outcomes of COVID-19 patients with acute ischemic stroke: A prospective, observational, single-center study in North Jordan. Medicine (Baltimore) 2022;101:e29834. [PMID: 35777044 DOI: 10.1097/MD.0000000000029834] [Reference Citation Analysis]
16 ter Ellen BM, Niewold J, Flikweert A, Muller Kobold AC, Heeringa P, van Meurs M, Smit JM, van der Voort PHJ, Rodenhuis-zybert IA, Moser J. Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro. Front Immunol 2022;13:879033. [DOI: 10.3389/fimmu.2022.879033] [Reference Citation Analysis]
17 Gennari-felipe M, Borges L, Dermargos A, Weimann E, Curi R, Pithon-curi TC, Hatanaka E. Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy. Front Med 2022;9:917008. [DOI: 10.3389/fmed.2022.917008] [Reference Citation Analysis]
18 Li X, Zhang Z, Wang Z, Gutiérrez-Castrellón P, Shi H. Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19. Signal Transduct Target Ther 2022;7:186. [PMID: 35697684 DOI: 10.1038/s41392-022-01043-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Singh R, Rathore SS, Khan H, Karale S, Chawla Y, Iqbal K, Bhurwal A, Tekin A, Jain N, Mehra I, Anand S, Reddy S, Sharma N, Sidhu GS, Panagopoulos A, Pattan V, Kashyap R, Bansal V. Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression. Front Endocrinol 2022;13:780872. [DOI: 10.3389/fendo.2022.780872] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00856-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell 2022;21:e13646. [PMID: 35645319 DOI: 10.1111/acel.13646] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mangiafico M, Caff A, Costanzo L. The Role of Heparin in COVID-19: An Update after Two Years of Pandemics. JCM 2022;11:3099. [DOI: 10.3390/jcm11113099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ripamonti C, Spadotto V, Pozzi P, Stevenazzi A, Vergani B, Marchini M, Sandrone G, Bonetti E, Mazzarella L, Minucci S, Steinkühler C, Fossati G. HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19. Front Immunol 2022;13:841716. [PMID: 35592335 DOI: 10.3389/fimmu.2022.841716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Bilge Ö, Kömek H, Kepenek F, Taştan E, Gündoğan C, Tatli İ, Öztürk C, Akin H, Işik F, Kavak Ş, Aslan B, Akyüz A, Kanbal Çap N, Erdoğan E. The effect of coronavirus disease 2019 pneumonia on myocardial ischemia detected by single-photon emission computed tomography myocardial perfusion imaging. Nucl Med Commun 2022. [PMID: 35506288 DOI: 10.1097/MNM.0000000000001569] [Reference Citation Analysis]
25 Simonetto M, Wechsler PM, Merkler AE. Stroke Treatment in the Era of COVID-19: a Review. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00713-8] [Reference Citation Analysis]
26 Edilgireeva LA, Sadulaeva TA, Zakharov VV, Vakhnina NV. [The effect of antiplatelet therapy on the course of COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova 2022;122:16-21. [PMID: 35394714 DOI: 10.17116/jnevro202212203116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ho CY, Salimian M, Hegert J, O'Brien J, Choi SG, Ames H, Morris M, Papadimitriou JC, Mininni J, Niehaus P, Burke A, Canbeldek L, Jacobs J, LaRocque A, Patel K, Rice K, Li L, Johnson R, LeFevre A, Blanchard T, Shaver CM, Moyer A, Drachenberg C. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19. JAMA Neurol 2022. [PMID: 35404378 DOI: 10.1001/jamaneurol.2022.0154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Beltrán-camacho L, Eslava-alcón S, Rojas-torres M, Sánchez-morillo D, Martinez-nicolás MP, Martín-bermejo V, de la Torre IG, Berrocoso E, Moreno JA, Moreno-luna R, Durán-ruiz MC. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00465-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Shah SM, Odanovic N, Kunnirickal S, Feher A, Pfau SE, Spatz ES. Chest pain and coronary endothelial dysfunction after recovery from COVID‐19: A case series. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5612] [Reference Citation Analysis]
30 Dolci M, Signorini L, D'Alessandro S, Perego F, Parapini S, Sommariva M, Taramelli D, Ferrante P, Basilico N, Delbue S. In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release. Int J Mol Sci 2022;23:4063. [PMID: 35409421 DOI: 10.3390/ijms23074063] [Reference Citation Analysis]
31 Maldonado F, Morales D, Díaz-Papapietro C, Valdés C, Fernandez C, Valls N, Lazo M, Espinoza C, González R, Gutiérrez R, Jara Á, Romero C, Cerda O, Cáceres M. Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support. Front Med (Lausanne) 2022;9:826218. [PMID: 35372407 DOI: 10.3389/fmed.2022.826218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Balakrishna Pillai A, Jeanpierre AR, Mariappan V, Ranganadin P, S.r. R. Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses. Cell Stress and Chaperones. [DOI: 10.1007/s12192-022-01269-x] [Reference Citation Analysis]
33 Hollenberg MD, Epstein M. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. Kidney International Supplements 2022;12:48-62. [DOI: 10.1016/j.kisu.2021.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
34 Poredoš P, Cífková R, Marie Maier JA, Nemcsik J, Šabovič M, Jug B, Ježovnik MK, Schernthaner GH, Antignani PL, Catalano M, Fras Z, Höbaus C, Nicolaides AN, Paraskevas KI, Reiner Ž, Wohlfahrt P, Poredoš P, Blinc A. Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events? Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Sbirkov Y, Dzharov V, Todorova K, Hayrabedyan S, Sarafian V. Endothelial inflammation and dysfunction in COVID-19. Vasa 2022;51:62-70. [PMID: 35171039 DOI: 10.1024/0301-1526/a000991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Martyanov AA, Boldova AE, Stepanyan MG, An OI, Gur'ev AS, Kassina DV, Volkov AY, Balatskiy AV, Butylin AA, Karamzin SS, Filimonova EV, Tsarenko SV, Roumiantsev SA, Rumyantsev AG, Panteleev MA, Ataullakhanov FI, Sveshnikova AN. Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status. Thrombosis Research 2022;211:27-37. [DOI: 10.1016/j.thromres.2022.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: Current Evidence and Perspectives. High Blood Press Cardiovasc Prev 2022. [PMID: 35184271 DOI: 10.1007/s40292-022-00506-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
38 Savastano MC, Larici AR, Crincoli E, De Filippis A, Cicchetti G, Gambini G, Savastano A, Marano R, Natale L, Rizzo S. Retinal vascular impairment matched to the pulmonary damage in early post-COVID 19 patients. Eur J Ophthalmol 2022;:11206721221079153. [PMID: 35174719 DOI: 10.1177/11206721221079153] [Reference Citation Analysis]
39 Maranini B, Ciancio G, Ferracin M, Cultrera R, Negrini M, Sabbioni S, Govoni M. microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life 2022;12:288. [DOI: 10.3390/life12020288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Jung O, Tung YT, Sim E, Chen YC, Lee E, Ferrer M, Song MJ. Development of human-derived, three-dimensional respiratory epithelial tissue constructs with perfusable microvasculature on a high-throughput microfluidics screening platform. Biofabrication 2022;14. [PMID: 35166694 DOI: 10.1088/1758-5090/ac32a5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. J Biol Chem 2022;:101695. [PMID: 35143839 DOI: 10.1016/j.jbc.2022.101695] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
42 Scarlat G, Dona B, Procopiescu B, Stoian M. Post-Covid-19 Immunological Disorder: A Possible Pathological Entity in a 43 Year Old Man. Internal Medicine 2022;19:77-94. [DOI: 10.2478/inmed-2022-0210] [Reference Citation Analysis]
43 Mohammed SA, Shaaban EIA. Efficacious nanomedicine track toward combating COVID-19. Nanotechnology Reviews 2022;11:680-98. [DOI: 10.1515/ntrev-2022-0036] [Reference Citation Analysis]
44 Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath. Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2031975] [Reference Citation Analysis]
45 Jarius S, Pache F, Körtvelyessy P, Jelčić I, Stettner M, Franciotta D, Keller E, Neumann B, Ringelstein M, Senel M, Regeniter A, Kalantzis R, Willms JF, Berthele A, Busch M, Capobianco M, Eisele A, Reichen I, Dersch R, Rauer S, Sandner K, Ayzenberg I, Gross CC, Hegen H, Khalil M, Kleiter I, Lenhard T, Haas J, Aktas O, Angstwurm K, Kleinschnitz C, Lewerenz J, Tumani H, Paul F, Stangel M, Ruprecht K, Wildemann B; ; in cooperation with the German Society for Cerebrospinal Fluid Diagnostics and Clinical Neurochemistry. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation 2022;19. [DOI: 10.1186/s12974-021-02339-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
46 Won T, Wood MK, Hughes DM, Talor MV, Ma Z, Schneider J, Skinner JT, Asady B, Goerlich E, Halushka MK, Hays AG, Kim DH, Parikh CR, Rosenberg AZ, Coppens I, Johns RA, Gilotra NA, Hooper JE, Pekosz A, Čiháková D. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 2022;75:103812. [PMID: 35033854 DOI: 10.1016/j.ebiom.2022.103812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, Wiersinga WJ, van Vugt M, Weijs PJM, Murray AJ, Wüst RCI. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle 2022;13:11-22. [PMID: 34997689 DOI: 10.1002/jcsm.12896] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
48 Ogungbe O, Kumbe B, Fadodun O, Latha T, Meyer D, Asala A, Davidson PM, Dennison Himmelfarb CR, Post WS, Commodore-Mensah Y. Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients. Int J Cardiol Heart Vasc 2022;:100950. [PMID: 35005211 DOI: 10.1016/j.ijcha.2021.100950] [Reference Citation Analysis]
49 Santamarina MG, Beddings I, Lomakin FM, Boisier Riscal D, Gutiérrez Claveria M, Vidal Marambio J, Retamal Báez N, Pavez Novoa C, Reyes Allende C, Ferreira Perey P, Gutiérrez Torres M, Villalobos Mazza C, Vergara Sagredo C, Ahumada Bermejo S, Labarca Mellado E, Barthel Munchmeyer E, Marchant Ramos S, Volpacchio M, Vega J. Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial. Crit Care 2022;26:1. [PMID: 34980198 DOI: 10.1186/s13054-021-03885-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Verta R, Grange C, Skovronova R, Tanzi A, Peruzzi L, Deregibus MC, Camussi G, Bussolati B. Generation of Spike-Extracellular Vesicles (S-EVs) as a Tool to Mimic SARS-CoV-2 Interaction with Host Cells. Cells 2022;11:146. [PMID: 35011708 DOI: 10.3390/cells11010146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ben Moftah M, Eswayah A. Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role. Assay Drug Dev Technol 2022;20:55-62. [PMID: 34990284 DOI: 10.1089/adt.2021.090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022;322:C1-C11. [PMID: 34817268 DOI: 10.1152/ajpcell.00375.2021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 30.0] [Reference Citation Analysis]
53 Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, Bharadiya V, Berry P, Ghosh T, Patel L, Sarda R, Garg S, Agarwal S, Arora V, Ramprasad A, Kumar A, Garg RK, Kodan P, Nischal N, Singh G, Jorwal P, Kumar A, Baitha U, Meena VP, Ray A, Sethi P, Xess I, Vikram N, Sinha S, Biswas A, Thakar A, Bhatnagar S, Trikha A, Wig N. Risk factors for Coronavirus disease-associated mucormycosis. J Infect 2021:S0163-4453(21)00654-X. [PMID: 34974056 DOI: 10.1016/j.jinf.2021.12.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
54 Volpe N, Ghi T. Re: SARS-CoV-2 behavior, through the eyes of a perinatologist? J Perinat Med 2021. [PMID: 34962365 DOI: 10.1515/jpm-2021-0642] [Reference Citation Analysis]
55 Rungjirajittranon T, Owattanapanich W, Leelakanok N, Sasijareonrat N, Suwanawiboon B, Chinthammitr Y, Ruchutrakool T. Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2021;27:10760296211069082. [PMID: 34907791 DOI: 10.1177/10760296211069082] [Reference Citation Analysis]
56 Kryukov EV, Ivanov AV, Karpov VO, Vasil’evich Aleksandrin V, Dygai AM, Kruglova MP, Kostiuchenko GI, Kazakov SP, Kubatiev AA, Sainaghi PP. Plasma S-Adenosylmethionine Is Associated with Lung Injury in COVID-19. Disease Markers 2021;2021:1-10. [DOI: 10.1155/2021/7686374] [Reference Citation Analysis]
57 Biering SB, de Sousa FTG, Tjang LV, Pahmeier F, Ruan R, Blanc SF, Patel TS, Worthington CM, Glasner DR, Castillo-Rojas B, Servellita V, Lo NTN, Wong MP, Warnes CM, Sandoval DR, Clausen TM, Santos YA, Ortega V, Aguilar HC, Esko JD, Chui CY, Pak JE, Beatty PR, Harris E. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling. bioRxiv 2021:2021. [PMID: 34931188 DOI: 10.1101/2021.12.10.472112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Updat 2021;:100794. [PMID: 34991982 DOI: 10.1016/j.drup.2021.100794] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Souza Junior DR, Silva ARM, Rosa-Fernandes L, Reis LR, Alexandria G, Bhosale SD, Ghilardi FR, Dalçóquio TF, Bertolin AJ, Nicolau JC, Marinho CRF, Wrenger C, Larsen MR, Siciliano RF, Di Mascio P, Palmisano G, Ronsein GE. HDL proteome remodeling associates with COVID-19 severity. J Clin Lipidol 2021;15:796-804. [PMID: 34802985 DOI: 10.1016/j.jacl.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Çap M, Bilge Ö, Gündoğan C, Tatlı İ, Öztürk C, Taştan E, Kepenek F, Işık F, Okşul M, Oktay M, Akyüz A, Erdoğan E, Burak C, Süleymanoğlu M, Karagöz A, Tanboğa İH. SPECT myocardial perfusion imaging identifies myocardial ischemia in patients with a history of COVID-19 without coronary artery disease. Int J Cardiovasc Imaging 2021. [PMID: 34811596 DOI: 10.1007/s10554-021-02477-9] [Reference Citation Analysis]
61 Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, Jannini EA. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sex Med Rev 2021:S2050-0521(21)00085-8. [PMID: 34933829 DOI: 10.1016/j.sxmr.2021.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
62 Peñalvo JL, Mertens E, Ademović E, Akgun S, Baltazar AL, Buonfrate D, Čoklo M, Devleesschauwer B, Diaz Valencia PA, Fernandes JC, Gómez EJ, Hynds P, Kabir Z, Klein J, Kostoulas P, Llanos Jiménez L, Lotrean LM, Majdan M, Menasalvas E, Nguewa P, Oh IH, O'Sullivan G, Pereira DM, Reina Ortiz M, Riva S, Soriano G, Soriano JB, Spilki F, Tamang ME, Trofor AC, Vaillant M, Van Ierssel S, Vuković J, Castellano JM; unCoVer network. Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol. BMJ Open 2021;11:e055630. [PMID: 34794999 DOI: 10.1136/bmjopen-2021-055630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Karki P, Birukova AA. Microtubules as Major Regulators of Endothelial Function: Implication for Lung Injury. Front Physiol 2021;12:758313. [PMID: 34777018 DOI: 10.3389/fphys.2021.758313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Roy S, Demmer RT. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes. Transl Res 2021:S1931-5244(21)00265-6. [PMID: 34763125 DOI: 10.1016/j.trsl.2021.11.002] [Reference Citation Analysis]
65 Deek SA. BPC 157 as Potential Treatment for COVID-19. Med Hypotheses 2021;158:110736. [PMID: 34798584 DOI: 10.1016/j.mehy.2021.110736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Oates CP, Bienstock SW, Miller M, Giustino G, Danilov T, Kukar N, Kocovic N, Sperling D, Singh R, Benhuri D, Beerkens F, Camaj A, Lerakis S, Croft L, Stein LK, Goldman ME. Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19. J Stroke Cerebrovasc Dis 2021;31:106217. [PMID: 34826678 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106217] [Reference Citation Analysis]
67 Wang J, Mei F, Bai L, Zhou S, Liu D, Yao L, Ahluwalia A, Ghiladi RA, Su L, Shu T, Gong M, Wang X, Zhu L, Cai K, Zhang X. Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications? Free Radic Biol Med 2021;175:216-25. [PMID: 34474106 DOI: 10.1016/j.freeradbiomed.2021.08.237] [Reference Citation Analysis]
68 Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, Owen A, Liptrott NJ. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev 2021;178:113848. [PMID: 34182016 DOI: 10.1016/j.addr.2021.113848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
69 Benedetti F, Silvestri G, Mavian C, Weichseldorfer M, Munawwar A, Cash MN, Dulcey M, Vittor AY, Ciccozzi M, Salemi M, Latinovic OS, Zella D. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses 2021;13:2193. [PMID: 34834998 DOI: 10.3390/v13112193] [Reference Citation Analysis]
70 Hernandez M, González-Zamora J, Recalde S, Moreno-Orduña M, Bilbao-Malavé V, Saenz de Viteri M, Landecho MF, Fernandez-Robredo P, García-Layana A. Evaluation of Macular Retinal Vessels and Histological Changes in Two Cases of COVID-19. Biomedicines 2021;9:1546. [PMID: 34829775 DOI: 10.3390/biomedicines9111546] [Reference Citation Analysis]
71 Daher J. Endothelial dysfunction and COVID-19 (Review). Biomed Rep 2021;15:102. [PMID: 34667599 DOI: 10.3892/br.2021.1478] [Reference Citation Analysis]
72 Kifle ZD, Woldeyohanis AE, Demeke CA. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19. Metabol Open 2021;12:100137. [PMID: 34664036 DOI: 10.1016/j.metop.2021.100137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Matli K, Chamoun N, Fares A, Zibara V, Al-Osta S, Nasrallah R, Salameh P, Mokhbat J, Ghanem G. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study. Open Heart 2021;8:e001785. [PMID: 34611018 DOI: 10.1136/openhrt-2021-001785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
75 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
76 Coleman MJ, Zimmerly KM, Yang XO. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients. Biomolecules 2021;11:1425. [PMID: 34680058 DOI: 10.3390/biom11101425] [Reference Citation Analysis]
77 Kryukov EV, Ivanov AV, Karpov VO, Vasil'evich Alexandrin V, Dygai AM, Kruglova MP, Kostiuchenko GI, Kazakov SP, Kubatiev AA. Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019. Oxid Med Cell Longev 2021;2021:9221693. [PMID: 34557267 DOI: 10.1155/2021/9221693] [Reference Citation Analysis]
78 Kalicińska E, Biernat M, Rybka J, Zińczuk A, Janocha-Litwin J, Rosiek-Biegus M, Morawska M, Waszczuk-Gajda A, Drozd-Sokołowska J, Szukalski Ł, Rymko M, Jabłonowska P, Simon K, Wróbel T. Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study. J Clin Med 2021;10:4373. [PMID: 34640390 DOI: 10.3390/jcm10194373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
79 Hsieh TC, Edwards NC, Bhattacharyya SK, Nitschelm KD, Burnett AL. The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective. Sex Med Rev 2021:S2050-0521(21)00077-9. [PMID: 34732316 DOI: 10.1016/j.sxmr.2021.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
80 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
81 Ji W, Hu Q, Zhang M, Zhang C, Chen C, Yan Y, Zhang X, Chen S, Tao L, Zhang W, Jin Y, Duan G. The Disruption of the Endothelial Barrier Contributes to Acute Lung Injury Induced by Coxsackievirus A2 Infection in Mice. Int J Mol Sci 2021;22:9895. [PMID: 34576058 DOI: 10.3390/ijms22189895] [Reference Citation Analysis]
82 Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519 [PMID: 34588748 DOI: 10.3748/wjg.v27.i33.5502] [Reference Citation Analysis]
83 Chow JH, Yin Y, Yamane DP, Davison D, Keneally RJ, Hawkins K, Parr KG, Al-Mashat M, Berger JS, Bushardt RL, Mazzeffi MA, Nelson SJ. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis. J Thromb Haemost 2021;19:2814-24. [PMID: 34455688 DOI: 10.1111/jth.15517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Michel-Chávez A, García-Grimshaw M, Chávez-Martínez OA, Cantú-Brito C, Romero-Sánchez GT, Flores-Silva FD, Merayo-Chalico FJ, Martínez-Carrillo FM, Barrera-Vargas A, Valdés-Ferrer SI. Posterior reversible encephalopathy syndrome during convalescence from COVID-19. Int J Neurosci 2021;:1-4. [PMID: 34370958 DOI: 10.1080/00207454.2021.1966629] [Reference Citation Analysis]
85 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Shraim BA, Moursi MO, Benter IF, Habib AM, Akhtar S. The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications. Front Pharmacol 2021;12:701390. [PMID: 34408653 DOI: 10.3389/fphar.2021.701390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Prakash H, Skiada A, Paul RA, Chakrabarti A, Rudramurthy SM. Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis. J Fungi (Basel) 2021;7:616. [PMID: 34436155 DOI: 10.3390/jof7080616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
89 Premeaux TA, Mediouni S, Leda A, Furler RL, Valente ST, Fine HA, Nixon DF, Ndhlovu LC. Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research. mBio 2021;12:e0068021. [PMID: 34253056 DOI: 10.1128/mBio.00680-21] [Reference Citation Analysis]
90 Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther 2021;6:266. [PMID: 34253708 DOI: 10.1038/s41392-021-00690-5] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
91 Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, Wörsdörfer P, Midkiff CC, Mudd J, Belyaeva E, Milligan NS, Rorison TD, Wagner N, Bodem J, Dölken L, Aktas BH, Vander Heide RS, Yin XM, Kolls JK, Roy CJ, Rappaport J, Ergün S, Qin X. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro. Front Cell Infect Microbiol 2021;11:701278. [PMID: 34307198 DOI: 10.3389/fcimb.2021.701278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
92 García-Grimshaw M, Chiquete E, Jiménez-Ruiz A, Vidal-Mayo JJ, Grajeda-González SL, Vargas-Martínez MLÁ, Toapanta-Yanchapaxi LN, Valdés-Ferrer SI, Chávez-Martínez OA, Marché-Fernández OA, Jiménez-Ávila AI, Cantú-Brito C, Flores-Silva FD. Delirium and Associated Factors in a Cohort of Hospitalized Patients With Coronavirus Disease 2019. J Acad Consult Liaison Psychiatry 2021:S2667-2960(21)00117-8. [PMID: 34242847 DOI: 10.1016/j.jaclp.2021.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
93 Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, Fleming I, Bibli SI, Jakobi T, Dieterich C, Zeiher AM, Ciesek S, Cinatl J, Dimmeler S. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol 2021;116:42. [PMID: 34224022 DOI: 10.1007/s00395-021-00882-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Cook JR, Ausiello J. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19. Rev Endocr Metab Disord 2021. [PMID: 34195965 DOI: 10.1007/s11154-021-09663-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
95 Sušić L, Maričić L, Vincelj J, Vadoci M, Sušić T. Understanding the association between endothelial dysfunction and left ventricle diastolic dysfunction in development of coronary artery disease and heart failure. Acta Biomed 2021;92:e2021204. [PMID: 34212905 DOI: 10.23750/abm.v92i3.11495] [Reference Citation Analysis]
96 Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog 2021;17:e1009634. [PMID: 34157054 DOI: 10.1371/journal.ppat.1009634] [Reference Citation Analysis]
97 Sztajnbok J, Brasil LMCR, Romero LA, Ribeiro AF, Vidal JE, Figueiredo-Mello C, Malaque CMSA. Splenic infarction with aortic thrombosis in COVID-19. Am J Med Sci 2021:S0002-9629(21)00238-X. [PMID: 34161825 DOI: 10.1016/j.amjms.2021.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev 2021:S1359-6101(21)00054-X. [PMID: 34183243 DOI: 10.1016/j.cytogfr.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Matli K, Farah R, Maalouf M, Chamoun N, Costanian C, Ghanem G. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021;8:e001628. [PMID: 34099529 DOI: 10.1136/openhrt-2021-001628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
100 Chiappalupi S, Salvadori L, Donato R, Riuzzi F, Sorci G. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk. Biomolecules 2021;11:876. [PMID: 34204735 DOI: 10.3390/biom11060876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Aparisi Á, Ybarra-Falcón C, García-Gómez M, Tobar J, Iglesias-Echeverría C, Jaurrieta-Largo S, Ladrón R, Uribarri A, Catalá P, Hinojosa W, Marcos-Mangas M, Fernández-Prieto L, Sedano-Gutiérrez R, Cusacovich I, Andaluz-Ojeda D, de Vega-Sánchez B, Recio-Platero A, Sanz-Patiño E, Calvo D, Baladrón C, Carrasco-Moraleja M, Disdier-Vicente C, Amat-Santos IJ, San Román JA. Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective Evaluation. J Clin Med 2021;10:2591. [PMID: 34208271 DOI: 10.3390/jcm10122591] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
102 Sarda R, Swain S, Ray A, Wig N. COVID-19 associated Mucormycosis: An epidemic within a pandemic. QJM 2021:hcab165. [PMID: 34109406 DOI: 10.1093/qjmed/hcab165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
103 Bertoletti L, Bikdeli B, Zuily S, Blondon M, Mismetti P. Thromboprophylaxis strategies to improve the prognosis of COVID-19. Vascul Pharmacol 2021;139:106883. [PMID: 34091065 DOI: 10.1016/j.vph.2021.106883] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Jover E, Matilla L, Garaikoetxea M, Fernández-Celis A, Muntendam P, Jaisser F, Rossignol P, López-Andrés N. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines 2021;9:639. [PMID: 34204890 DOI: 10.3390/biomedicines9060639] [Reference Citation Analysis]
105 Spinelli FR, Meylan F, O'Shea JJ, Gadina M. JAK inhibitors: Ten years after. Eur J Immunol 2021;51:1615-27. [PMID: 33930196 DOI: 10.1002/eji.202048922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
106 Costa B, Vale N. A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19. Pharmaceutics 2021;13:815. [PMID: 34070725 DOI: 10.3390/pharmaceutics13060815] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Ambrosino P, Molino A, Calcaterra I, Formisano R, Stufano S, Spedicato GA, Motta A, Papa A, Di Minno MND, Maniscalco M. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation. Biomedicines 2021;9:614. [PMID: 34071308 DOI: 10.3390/biomedicines9060614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, Bernal-Morel E, Courel-Ibáñez J. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health 2021;18:5329. [PMID: 34067776 DOI: 10.3390/ijerph18105329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
109 Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Steffes LC, Cornfield DN. Coronavirus disease 2019 respiratory disease in children: clinical presentation and pathophysiology. Curr Opin Pediatr 2021;33:302-10. [PMID: 33938476 DOI: 10.1097/MOP.0000000000001013] [Reference Citation Analysis]
113 Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CBF, Lu-Culligan WJ, Campbell KH, Casanovas-Massana A, Bermejo S, Toothaker JM, Lee HJ, Liu F, Schulz W, Fournier J, Muenker MC, Moore AJ, Konnikova L, Neugebauer KM, Ring A, Grubaugh ND, Ko AI, Morotti R, Guller S, Kliman HJ, Iwasaki A, Farhadian SF; Yale IMPACT Team. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y) 2021;2:591-610.e10. [PMID: 33969332 DOI: 10.1016/j.medj.2021.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
114 Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy 2021;13:753-65. [PMID: 33906375 DOI: 10.2217/imt-2020-0349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
115 Kessel C, Vollenberg R, Masjosthusmann K, Hinze C, Wittkowski H, Debaugnies F, Nagant C, Corazza F, Vély F, Kaplanski G, Girard-Guyonvarc'h C, Gabay C, Schmidt H, Foell D, Tepasse PR. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers. Arthritis Rheumatol 2021. [PMID: 33880885 DOI: 10.1002/art.41763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
116 Manzoor D, Bui C, Makhoul E, Luthringer D, Marchevsky A, Volod O. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports. Medicine (Baltimore) 2021;100:e25255. [PMID: 33847623 DOI: 10.1097/MD.0000000000025255] [Reference Citation Analysis]
117 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
118 Levy JH, Iba T, Gardiner EE. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. Arterioscler Thromb Vasc Biol 2021;41:1774-6. [PMID: 33792345 DOI: 10.1161/ATVBAHA.121.316101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
121 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
122 Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, Lefevre G, Lassalle F, Bauters A, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Vincent F, Rousse N, Kipnis E, Lenting P, Poissy J, Susen S; Lille Covid Research Network (LICORNE). Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19. Arterioscler Thromb Vasc Biol 2021;41:1760-73. [PMID: 33626910 DOI: 10.1161/ATVBAHA.120.315595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
123 Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med 2021;8:619690. [PMID: 33718448 DOI: 10.3389/fcvm.2021.619690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
124 Ackermann M, Werlein C, Länger F, Kühnel MP, Jonigk DD. [COVID-19: effects on the lungs and heart]. Pathologe 2021;42:164-71. [PMID: 33560456 DOI: 10.1007/s00292-021-00918-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]